根治性前列腺切除术在转移性前列腺癌患者中的研究进展  

Research progress of radical prostatectomy in patients with metastatic prostate cancer

作　　者：张崇剑 白宇[2] ZHANG Chongjian;BAI Yu(Graduate School,Kunming Medical University,Yunnan Province,Kunming 650100,China;Department of Urology,the Third Affiliated Hospital of Kunming Medical University,Yunnan Province,Kunming 650100,China)

机构地区：[1]昆明医科大学研究生院,云南昆明650100 [2]昆明医科大学第三附属医院泌尿外科,云南昆明650100

出　　处：《中国医药导报》2019年第27期53-55,共3页China Medical Herald

摘　　要：根治性前列腺切除术一直是早期前列腺癌的主要治疗方法,而转移性前列腺癌(mPCa)大多采用内分泌治疗等保守治疗方式。近年来,随着对疾病机制的深入认识和手术技术的不断进步,手术对于mPCa的治疗作用逐渐被某些学者认可,现通过分析临床、生物学基础等方面的研究,系统综述根治性前列腺切除术在mPCa患者中的研究现况及对未来的研究展望。Radical prostatectomy has always been the main treatment for early prostate cancer. For metastatic prostate cancer (mPCa), most conservative treatments such as endocrine therapy are used. In recent years, with the deep understanding of the mechanism of prostate cancer and the continuous advancement of surgical techniques, the role of surgery in mPCa has gradually been recognized by some scholars. It is now systematically reviewed that the current status of prostatectomy in patients with mPCa through clinical research analysis and basic biological research, and prospects for future research.

关 键 词：根治性前列腺切除术 转移性前列腺癌 减瘤性根治性前列腺切除术 

分 类 号：R737.25[医药卫生—肿瘤]